definiens: means the cost of launching a Collaboration Produ ct, to the extent incurred prior to First Commercial Sale, i ncluding the costs associated with : ( i)Agency and promotional materials ( e.g., positioning, message development, core sales aid, annotated package insert, campaign, and patient materials / p atient advocacy ) ; ( ii)E - marketing ( e.g., website development and other online promotion mar keting ) ; ( iii)Access solutions preparation and support mater ials ( e.g. patient co - pay information and other assistance programs such as free drug ) ; ( iv)Sales training meeting and materials developmen t ( including online or in person training ) ; ( v)Nurse and pharmacist materials ; 14 CONFIDENTIALEXECUTION COPY ( vi)Launch meeting and materials ( e.g., motivational patient videos ) ; ( vii)Contracting and other national accounts activi ties ; ( viii)Promotional advisory boards ( various audience s ) ; ( ix)Promotional speaker bureaus ( including medical doctors and nurses ) ; ( x)Booth materials and visuals ( e.g., videos and mechanism of action animations ) ; ( xi)Non - promotional scientific materials and brochu res ; ( xii)Therapeutic area expert identification and adv isory boards ; ( xiii)Scientific / clinical story and message develop ment and associated publications agency support including reprints ; ( xiv)Market research, including primary and seconda ry market research, including payor research, and market analytics and forecasting ; ( xv ) Costs for Medical Affairs Activities ( not incl uding Clinical Studies, which are Development Costs ) prior to the First Commercial Sale in the Territory ; and ( xvi)Any other costs and expense of [COMPANY], its Affiliates, and its sublicensees specifically ident ifiable or reasonably allocable to the launch of a Collabor ation Product prior to First Commercial Sale as consistently applied across its portfolio